All News #Library
Quality
Intercept Receives CRL from FDA Addressing OCALIVA Snda
12 Nov 2024 //
GLOBENEWSWIRE
Intercept restructures as NASH hopes dashed again by FDA
23 Jun 2023 //
FIERCE PHARMA
FDA rejects Intercept’s pitch for NASH as CEO fires back ‘evolving’ guidelines
30 Jun 2020 //
ENDPTS

Market Place
Sourcing Support